Clinical Trial Update: Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.

View source ↗

Summary

An observational clinical trial update evaluating whether the IOpener-Melanoma Test can predict response to immunotherapy in patients with advanced melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• IOpener-Melanoma Test

Snippet

Sponsor: Pamgene International B.V. | Conditions: Melanoma Metastatic, Melanoma, Skin | Status: RECRUITING